ApaTech’s Growing Pedigree

ApaTech’s Growing Pedigree
By Walter Eisner February 2, 2009
Britain’s fastest growing private medical technology company, ApaTech Inc., has added the pedigree of Johnson and Johnson, Medtronic and Kyphon to their front office as the company announced major new appointments in January.

The producer of Actifuse, a silicate-substituted calcium phosphate bone graft material, has operations in London, Boston, and Berlin and sells products in 21 countries.

Simon Cartmell, ApaTech’s CEO made the announcements on January 9. He said the company’s growth has been driven by the quality of the people the company has been able to hire and who are committed to the mission of redefining the orthobiologics market place.

The new hires include:

Jill Schiaparelli, Vice President – Commercial Strategy and Business Development, will be responsible for global commercial strategy and all U.S. and OUS marketing activities including commercial input to new product development and portfolio expansion through acquisition and licensing. Prior to joining ApaTech she held a series of global strategy and marketing positions at Johnson and Johnson, including Ethicon/Ethicon Endo.

Melanie Marshall, Vice President – Clinical Operations, will be responsible for the conduct of pre and post approval clinical studies and the acquisition of clinical data in support of marketing and regulatory objectives. Immediately before joining ApaTech, Marshall was responsible for clinical strategy and execution across several divisions of Boston Scientific, prior to which she gained extensive experience in the spine division of Medtronic.

Todd Clearwater, U.S. Vice President – National Sales, will be responsible for all U.S. sales and sales-related activities and previously set up and managed Kyphon’s national market expansion activities. Following his time at Kyphon, Todd served as Senior Vice President Sales at Interventional Spine Inc..

Both Schiaparelli and Marshall will report to Cartmell and become members of the company’s senior management team. Clearwater will report to ApaTech’s President, Steve Czick

ApaTech was recognized as Britain’s fastest growing medical technology company in both the 2008 and 2007 Sunday Times Fast Track 100 fastest growing private companies review.

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button